BusinessLink Revised - Dr. Schwartz CEO of SKLN and Dr. Garvin with CytoBioscience Discuss Positive Results of a Merger in Progress with Their Two CompaniesBy Nasdaq OMXAug 16, 2017, 2:57 PM UTC
BusinessDr. Schwartz CEO of SKLN and Dr. Garvin with CytoBioscience Discuss Positive Results of a Merger in Progress with Their Two CompaniesBy Nasdaq OMXAug 16, 2017, 1:00 PM UTC
BusinessMonsanto and ToolGen Announce Global Licensing Agreement on CRISPR Platform, Underscore the Benefits of Innovation for FarmersBy Nasdaq OMXAug 16, 2017, 12:30 PM UTC
BusinessProQR Announces Results for the Second Quarter of 2017By Nasdaq OMXAug 16, 2017, 11:00 AM UTC
BusinessOnconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 15, 2017, 11:00 AM UTC
BusinessOncoCyte Confirms Launch Plans for Lung Cancer Diagnostic Test; Reports Progress Toward CLIA Lab Licensing and Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 14, 2017, 8:10 PM UTC
BusinessArbutus to Present at 2017 Wedbush PacGrow Healthcare ConferenceBy Nasdaq OMXAug 14, 2017, 1:00 PM UTC
BusinessCOO Anthony Dudzinski was Interviewed on Uptick Network on Product Importance and Company ImprovementsBy Nasdaq OMXAug 14, 2017, 1:00 PM UTC
